中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基因1b型慢性丙型肝炎患者血清铁蛋白水平与聚乙二醇干扰素抗病毒疗效的关系

游春芳 周利民 邓薇

引用本文:
Citation:

基因1b型慢性丙型肝炎患者血清铁蛋白水平与聚乙二醇干扰素抗病毒疗效的关系

DOI: 10.3969/j.issn.1001-5256.2017.09.016
详细信息
  • 中图分类号: R512.63

Correlation between serum ferritin level and antiviral effect of pegylated interferon in chronic hepatitis C patients with genotype 1b

  • 摘要: 目的探讨分析慢性丙型肝炎(CHC)患者血清铁蛋白(SF)水平与PEG-IFNα-2a疗效的相关性。方法选取2013年11月-2014年7月自贡市第一人民医院收治的85例CHC患者,均给予PEG-IFNα-2a,180μg,皮下注射,每周1次,同时联合利巴韦林口服1015 mg·kg-1·d-1,疗程48周,治疗结束后随访24周。在0周时检测SF,在0、4、12、24、48及72周检测HCV RNA以判断疗效。根据疗效分为快速病毒学应答组(RVR)、早期病毒学应答组(EVR)、持续病毒学应答组(SVR)、无应答组、复发组;根据SF水平分为高SF组(≥400 ng/ml)与低SF组(<400 ng/ml)。计量资料多组间比较采用方差分析,进一步两两比较采用SNKq检验;计数资料组间比较采用χ2检验;相关性分析采用Spearman秩相关性分析。结果 85例CHC患者中获得RVR 36例(42.35%),EVR 70例(82.35%),SVR 68例(80.00%),无应答15例(17.65%),复发...

     

  • [1]MA LY, ZHANG P, CHEN Q, et al.Changes in number of peripheral blood cells in patients with chronic hepatitis C after treated with interferon alpha 2b combined with ribavirin and their clinical significances[J].J Jilin Univ:Med Edit, 2015, 41 (3) :599-605. (in Chinese) 马琳媛, 张鹏, 陈倩, 等.干扰素α-2b联合利巴韦林治疗后慢性丙型肝炎患者外周血细胞数量的变化及其临床意义[J].吉林大学学报:医学版, 2015, 41 (3) :599-605.
    [2]HE YM, HOU B.PEG-IFNα-2a and ribavirin for decompensated cirrhotic patients with hepatitis C after eliminating complications[J].Chin J Med Offic, 2017, 45 (4) :397-400. (in Chinese) 何妍梅, 侯波.聚乙二醇干扰素α-2a联合利巴韦林治疗失代偿期丙肝肝硬化并发症消除后患者临床观察[J].临床军医杂志, 2017, 45 (4) :397-400.
    [3]WU CX.Influence of serum glutamic-pyruvic transaminase level and hepatitis C virus RNA quantification on therapeutic effect of interferon in chronic hepatitis C patients[J].China Foreign Med Treatment, 2013, 32 (34) :56-57. (in Chinese) 吴晨曦.慢性丙肝患者血清谷丙转氨酶水平、丙肝病毒RNA定量对干扰素疗效的影响分析[J].中外医疗, 2013, 32 (34) :56-57.
    [4]DING L, ZHONG HY, SONG XB, et al.HCV genotype distribution in southwest China and its influence on patients’response to pegylated-interferonα-2a plus ribavirin therapy[J].J Sichuan Univ:Med Sci Edi, 2015, 46 (4) :573-577. (in Chinese) 丁柳, 钟慧钰, 宋兴勃, 等.四川人群丙肝病毒基因型分布及与抗病毒疗效的相关性[J].四川大学学报:医学版, 2015, 46 (4) :573-577.
    [5]LUO Q, WU CX, LI CM, et al.Effect of IL-28B gene polymorphism and expression on antiviral therapy of patients with chronic hepatitis C[J].J Chongqing Med Univ, 2015, 40 (3) :335-339. (in Chinese) 罗旗, 伍春霞, 李成敏, 等.白细胞介素28B基因多态性以及表达水平对慢性丙型肝炎患者抗病毒治疗效果的影响研究[J].重庆医科大学学报, 2015, 40 (3) :335-339.
    [6]KONG WL, YANG YL, XU HQ, et al.Relationship between liver function and virological response in patients with chronic hepatitis Cduring antiviral treatment[J].J Jilin Univ:Med Edit, 2016, 42 (1) :99-103. (in Chinese) 孔文丽, 杨以良, 徐洪芹, 等.慢性丙型肝炎患者抗病毒治疗中肝功能与病毒学应答的关系[J].吉林大学:医学版, 2016, 42 (1) :99-103.
    [7]DISTANTE S, BJORO K, HELLUM KB, et al.Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection[J].Liver, 2002, 22 (3) :269-275.
    [8]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
    [9]WEI L.Hepatitis C-clinical diagnosis and treatment manual[M].Beijing:Science Press, 2012. (in Chinese) 魏来.丙型肝炎-临床诊断与治疗手册[M].北京:科学出版社, 2012.
    [10]MEI L, ZHU WD, ZHU YH, et al.Clinical effect of pegylated interferonα-2a combined with ribavirin in treatment of patients with genotype 1b chronic hepatitis C[J].Chin Hepatol, 2014, 19 (12) :952-954. (in Chinese) 梅蕾, 祝卫东, 朱跃红, 等.聚乙二醇干扰素α-2a联合利巴韦林治疗基因1b型慢性丙型肝炎临床观察[J].肝脏, 2014, 19 (12) :952-954.
    [11]ZHAO JJ, LI J, LIU J, et al.Relationships of serum ferritin level, degree of liver inflammation and types in patients with liver disease[J].Shandong Med J, 2015, 55 (9) :21-23. (in Chinese) 赵晶晶, 李嘉, 刘洁, 等.肝病患者血清铁蛋白水平与肝脏炎症程度及肝病类型的关系[J].山东医药, 2015, 55 (9) :21-23.
    [12]WU KK, WU C.Research advances in the value of serum ferritin measurement in chronic viral hepatitis[J/CD].Chin J Clinicians:Electronic Edition, 2013, 7 (12) :5568-5570. (in Chinese) 武抗抗, 吴超.血清铁蛋白水平在慢性病毒性肝炎中检测意义的研究进展[J/CD].中华临床医师杂志:电子版, 2013, 7 (12) :5568-5570.
    [13]QIN Y, GUO YH, ZHANG Y, et al.Mechanism of iron metabolism disorder in patients with chronic hepatitis C[J].J Clin Hepatol, 2015, 31 (2) :291-294. (in Chinese) 秦源, 郭永红, 张颖, 等.慢性丙型肝炎铁代谢的失调机制[J].临床肝胆病杂志, 2015, 31 (2) :291-294.
    [14]LANGE CM, KUTALIK Z, MORIKAWA K, et al.Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis Cpoorly responding to pegylated interferon-alpha and ribavirin therapy[J].Hepatology, 2012, 55 (4) :1038-1047.
    [15]QI CW, CHEN Q, ZHANG XJ, et al.Research advances in abnormal iron metabolism in chronic hepatic C[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (2) :29-32. (in Chinese) 亓传旺, 陈倩, 张秀军, 等.慢性丙型肝炎铁代谢异常的研究进展[J/CD].中国肝脏病杂志:电子版, 2015, 7 (2) :29-32.
    [16]HOFER H, OSTERREICHER C, JESSNER W, et al.Hepaticiron concentration does not predict response to standard and pegylatedIFN/ribavirin therapy in patients with chronic hepatitis C[J].JHepatol, 2004, 40 (6) :1018-1022.
    [17]LADERO JM, LOPEZ-ALONSO G, DEVESA MJ, et al.Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C[J].Rev Esp Enterm Diq, 2009, 101 (1) :31-40.
    [18]BARUT S, GUNAL O, ERKORKMAZ U.Serum ferritin levels in chronic hepatitis C patients during antiviral therapy and prediction of treatment response[J].Scand J Infect Dis, 2012, 44 (10) :761-765.
    [19]GONG L, JING Z, JIANG Y, et al.Relationship between the level of serum ferritin and the effects of peginterferon alfa-2a in treating chronic hepatitis C patients[J].Chin J New Drugs Clin Rem, 2007, 26 (1) :59-61. (in Chinese) 龚玲, 景钊, 江宇, 等.血清铁蛋白与培干扰素α-2a治疗慢性丙型肝炎疗效的关系[J].中国新药与临床杂志, 2007, 26 (1) :59-61.
    [20]WALKER EM Jr, WALKER SM.Effects of iron overload on the immune system[J].Ann Clin Lab Sci, 2000, 30 (4) :354-365.
    [21]LIN W, SI JL, ZHANG J, et al.Pegylated interferon alpha-2a combined with ribavirin for chronic hepatitis C:a clinical analysis of160 patients of Uygur nationality or Han nationality[J].J Clin Hepatol, 2015, 31 (11) :1831-1836. (in Chinese) 林伟, 司建林, 张剑, 等.聚乙二醇干扰素α-2a联合利巴韦林治疗维吾尔族和汉族慢性丙型肝炎160例临床分析[J].临床肝胆病杂志, 2015, 31 (11) :1831-1836.
  • 加载中
计量
  • 文章访问数:  1906
  • HTML全文浏览量:  12
  • PDF下载量:  390
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-03-08
  • 出版日期:  2017-09-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回